logo-loader
viewFutura Medical PLC

Futura Medical PLC - Notice of AGM and Annual Report

RNS Number : 1186N
Futura Medical PLC
18 May 2020
 

 

18 May 2020

 

Notice of AGM and Annual Report

 

Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, announces its Annual General Meeting ("AGM") will be held at 10am on Wednesday, 24 June 2020, at the Company's Head Office, Surrey Technology Centre, 40 Occam Road, Guildford, GU2 7YG. The Company also publishes its Annual Report for the year ended 31 December 2019.

 

The Board has been closely monitoring the evolving Coronavirus (COVID-19) situation and recognises that UK Government guidance continues to require social distancing and prohibition of mass gatherings.

 

Only the minimum number of directors who are shareholders will attend in person to ensure a quorum is present. Accordingly, so as to ensure their vote is counted at the AGM, all shareholders are asked to submit a Form of Proxy, instructing the Chairman of the Meeting on how they wish to vote on the proposed resolutions. 

 

Shareholder engagement

The Board recognises the ongoing importance of communication with shareholders at this time. The Company will be providing a video conference call link to enable shareholders to follow proceedings of the meeting and potentially ask questions about the resolutions.  Any shareholders who wish to follow the meeting by video conference should contact the Company Secretary prior to the day of the meeting at [email protected] in order to request video conference dial-in details and to provide the requisite identification documents.

 

Reminder to vote by proxy

We urge all shareholders to register their vote in advance. You will not receive a hard copy form of proxy for the 2020 AGM in the post. Instead, you will be able to vote electronically using the link www.signalshares.com by logging into your Signal Shares account, or register if you have not previously done so. To register you will need your Investor Code, this is detailed on your share certificate or available from our Registrar, Link Asset Services. You may request a hard copy form of proxy directly from the registrars, Link Asset Services, on Tel: 0371 664 0391. Proxy votes must be received no later than 10:00 am on Monday, 22nd June 2020.

 

Further updates

The Board will continue to monitor the situation and may, if necessary, need to make further changes to the arrangements for the AGM, including how it is conducted. Shareholders should therefore continue to monitor the Company's website and announcements.

 

The Board would like to thank shareholders for their understanding and support during these exceptional circumstances and wish them well during these challenging times.

 

Annual Report

Futura's annual report and accounts for the year ended 31 December 2019 (the "Annual Report") is available to shareholders as an electronic communication pursuant to the Companies Act 2006 and is now available at the Company's website www.futuramedical.com, along with the notice of AGM.

 

 

 

-ENDS-

For further information please contact:

Futura Medical plc

James Barder, Chief Executive

Angela Hildreth, Finance Director and COO

Email: [email protected] 

Tel: +44 (0) 1483 685 670

www.Futuramedical.com

Nominated Adviser and Sole Broker:

Liberum

Bidhi Bhoma/ Euan Brown/ Kane Collings

Tel: +44 (0) 20 3100 2000

 

For media enquiries please contact:

 

Optimum Strategic Communications

Mary Clark/ Eva Haas/ Supriya Mathur

Email: [email protected]

Tel: +44 (0) 203 922 0891

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NOAEAXSSFADEEFA

Quick facts: Futura Medical PLC

Price: 16.5

Market: AIM
Market Cap: £40.53 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Futura Medical's James Barder says regulatory submissions for MED3000 remain...

Futura Medical PLC's (LON:FUM) James Barder tells Proactive London's Andrew Scott they've seen little impact from the coronavirus lockdown and that regulatory submissions for its erectile dysfunction treatment remain on track. The treatment is MED3000 - a fast-acting gel that will be targeted...

1 week, 3 days ago